{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:02:33Z","timestamp":1790827353602,"version":"4.1.0"},"reference-count":248,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.critrevonc.2025.104830","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T22:34:25Z","timestamp":1751582065000},"page":"104830","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Global perspective on the genetic, epigenetic, and transcriptomic basis of gallbladder cancer"],"prefix":"10.1016","volume":"214","author":[{"given":"Doutrina","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjusha","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1496-9846","authenticated-orcid":false,"given":"Manoj","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4326-5386","authenticated-orcid":false,"given":"Ruhi","family":"Dixit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.critrevonc.2025.104830_bib1","doi-asserted-by":"crossref","DOI":"10.21037\/cco.2019.07.03","article-title":"Management of gallbladder cancer in India","volume":"8","author":"Acharya","year":"2019","journal-title":"Chin. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104830_bib2","doi-asserted-by":"crossref","DOI":"10.21037\/cco.2019.06.06","article-title":"Gallbladder cancer: surgical management","volume":"8","author":"Krell","year":"2019","journal-title":"Chin. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jgo.2019.09.009","article-title":"Advancing age and the risk of bleomycin pulmonary toxicity in a largely older cohort of patients with newly diagnosed Hodgkin Lymphoma","volume":"11","author":"Thomas","year":"2020","journal-title":"J. Geriatr. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s00268-015-3267-2","article-title":"Does the frequency of cholecystectomy affect the ensuing incidence of gallbladder cancer in Sweden? A population-based study with a 16-year coverage","volume":"40","author":"Noel","year":"2016","journal-title":"World J. Surg."},{"key":"10.1016\/j.critrevonc.2025.104830_bib5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2147\/CLEP.S37357","article-title":"Gallbladder cancer: epidemiology and outcome","author":"Shaffer","year":"2014","journal-title":"Clin. Epidemiol."},{"issue":"43","key":"10.1016\/j.critrevonc.2025.104830_bib6","doi-asserted-by":"crossref","first-page":"12211","DOI":"10.3748\/wjg.v21.i43.12211","article-title":"Gallbladder carcinoma: prognostic factors and therapeutic options","volume":"21","author":"Goetze","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"21","key":"10.1016\/j.critrevonc.2025.104830_bib7","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1002\/cncr.30856","article-title":"Stereotactic body radiotherapy for unresected pancreatic cancer: A nationwide review","volume":"123","author":"De Geus","year":"2017","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104830_bib8","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1158\/2159-8290.CD-15-1545","article-title":"Analysis of immune signatures in longitudinal tumor samples yields insight into biomarkers of response and mechanisms of resistance to immune checkpoint blockade","volume":"6","author":"Chen","year":"2016","journal-title":"Cancer Discov."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104830_bib9","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104830_bib10","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1349-7006.2009.01458.x","article-title":"Epidemiology of cholangiocarcinoma: an update focusing on risk factors","volume":"101","author":"Shin","year":"2010","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.suronc.2008.07.002","article-title":"Helicobacter species are associated with possible increase in risk of hepatobiliary tract cancers","volume":"18","author":"Pandey","year":"2009","journal-title":"Surg. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104830_bib12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5114\/pg.2018.81072","article-title":"Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors","volume":"14","author":"Rawla","year":"2019","journal-title":"Gastroenterol. Rev. Gastroenterol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104830_bib13","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1007\/s10620-016-4438-1","article-title":"Comparative analysis of mutational profile of sonic hedgehog gene in gallbladder cancer","volume":"62","author":"Dixit","year":"2017","journal-title":"Dig. Dis. Sci."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104830_bib14","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104830_bib15","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/jso.20531","article-title":"Environmental pollutants in gallbladder carcinogenesis","volume":"93","author":"Pandey","year":"2006","journal-title":"J. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104830_bib16","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1046\/j.1365-2559.1998.00474.x","article-title":"Metallothionein expression in carcinoma of the gallbladder","volume":"33","author":"Shukla","year":"1998","journal-title":"Histopathology"},{"key":"10.1016\/j.critrevonc.2025.104830_bib17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00008469-200006000-00003","article-title":"Fatty acids, biliary bile acids, lipid peroxidation products and gallbladder carcinogenesis","author":"Pandey","year":"2000","journal-title":"Eur. J. Cancer Prev."},{"issue":"22","key":"10.1016\/j.critrevonc.2025.104830_bib18","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.3748\/wjg.v23.i22.3978","article-title":"Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update","volume":"23","author":"Sharma","year":"2017","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104830_bib19","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0025-7125(16)32741-9","article-title":"Genetic factors in carcinoma","volume":"53","author":"Lynch","year":"1969","journal-title":"Med Clin. North Am."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib20","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/1097-0142(197807)42:1<330::AID-CNCR2820420150>3.0.CO;2-F","article-title":"Natural history study of gallbladder cancer.A review of 36 years experience at M. D. Anderson hospital and tumor institute","volume":"42","author":"Perpetuo","year":"1978","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104830_bib21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0165-4608(79)90019-0","article-title":"Gallbladder cancer in Hispanic New Mexicans. II. Familial occurrence in two northern New Mexico kindreds","volume":"1","author":"Devor","year":"1979","journal-title":"Cancer Genet Cytogenet"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104830_bib22","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1136\/gut.52.4.592","article-title":"Familial liver and gall bladder cancer: a nationwide epidemiological study from Sweden","volume":"52","author":"Hemminki","year":"2003","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104830_bib23","first-page":"209","article-title":"Family history and the risk of liver, gallbladder, and pancreatic cancer","volume":"3","author":"Fernandez","year":"1994","journal-title":"Cancer Epidemiol. Biomark. Prev. Publ. Am. Assoc. Cancer Res Cosponsored Am. Soc. Prev. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104830_bib24","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/13547500600648697","article-title":"Genetic polymorphisms in GSTM1, GSTT1, GSTP1, GSTM3 and the susceptibility to gallbladder cancer in North India","volume":"11","author":"Pandey","year":"2006","journal-title":"Biomarkers"},{"key":"10.1016\/j.critrevonc.2025.104830_bib25","unstructured":"Miyazaki K., Imamura S., Ogawa Y., Nakayama F. Familial occurrence of anomalous pancreaticobiliary duct union associated with gallbladder neoplasms. Am J Gastroenterol Springer Nat [Internet]. 1989 [cited 2024 Oct 24];84(2). Available from: \u3008https:\/\/search.ebscohost.com\/login.aspx?direct=true&profile=ehost&scope=site&authtype=crawler&jrnl=00029270&AN=16252882&h=wDbJ0iM9HpvhceAgFl%2BXc5eiLPkqvIxlj3sVSNFoSWrPztQoXRqrpCajt91jSNFY6bU07G%2F7cU7ZSJAXHc34SQ%3D%3D&crl=c\u3009."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104830_bib26","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/ijc.22756","article-title":"Family history of gallstones and the risk of biliary tract cancer and gallstones: A population-based study in Shanghai, China","volume":"121","author":"Hsing","year":"2007","journal-title":"Int J. Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104830_bib27","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1365-2559.2004.01888.x","article-title":"Familial adenomatous polyposis associated with colon carcinoma, desmoid tumour, gallbladder carcinoma, and endometrioid carcinoma: a case report","volume":"45","author":"Hirano","year":"2004","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib28","first-page":"76","article-title":"Biliary neoplasia in Gardner\u2019s syndrome","volume":"111","author":"Walsh","year":"1987","journal-title":"Arch. Pathol. Lab Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s12029-015-9794-0","article-title":"Association of methylenetetrahydrafolate reductase gene polymorphism (MTHFR) in patients with gallbladder cancer","volume":"47","author":"Dixit","year":"2016","journal-title":"J. Gastrointest. Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104830_bib30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/jhg.2012.9","article-title":"A genome-wide association study identifies SNP in DCC is associated with gallbladder cancer in the Japanese population","volume":"57","author":"Cha","year":"2012","journal-title":"J. Hum. Genet"},{"key":"10.1016\/j.critrevonc.2025.104830_bib31","unstructured":"Mhatre: Common genetic variation and risk of gallbladder\u2026 - Google Scholar [Internet]. [cited 2024 Nov 28]. Available from: \u3008https:\/\/scholar.google.com\/scholar_lookup?title=Common%20genetic%20variation%20and%20risk%20of%20gallbladder%20cancer%20in%20India%3A%20a%20case-control%20genome-wide%20association%20study&publication_year=2017&author=S.%20Mhatre&author=Z.%20Wang&author=R.%20Nagrani&author=R.%20Badwe&author=S.%20Chiplunkar&author=B.%20Mittal&author=S.%20Yadav&author=H.%20Zhang&author=C.C.%20Chung&author=P.%20Patil&author=S.%20Chanock&author=R.%20Dikshit&author=N.%20Chatterjee&author=P.%20Rajaraman\u3009."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib32","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/s41598-018-35852-z","article-title":"Variants in ABCG8 and TRAF3 genes confer risk for gallstone disease in admixed Latinos with Mapuche Native American ancestry","volume":"9","author":"Bustos","year":"2019","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104830_bib33","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/cncr.32740","article-title":"Germline alterations in patients with biliary tract cancers: A spectrum of significant and previously underappreciated findings","volume":"126","author":"Maynard","year":"2020","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104830_bib34","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.7150\/thno.56539","article-title":"Mutational spectrum and precision oncology for biliary tract carcinoma","volume":"11","author":"Lin","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.critrevonc.2025.104830_bib35","article-title":"Comprehensive germline and somatic genomic profiles of Chinese patients with biliary tract cancer","volume":"12","author":"Yu","year":"2022","journal-title":"Front Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104830_bib36","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1365-2559.2008.03192.x","article-title":"Gallbladder cancer: a morphological and molecular update","volume":"55","author":"Goldin","year":"2009","journal-title":"Histopathology"},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104830_bib37","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/nrc1429","article-title":"Gallbladder cancer: lessons from a rare tumour","volume":"4","author":"Wistuba","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104830_bib38","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1002\/1097-0142(19821115)50:10<2226::AID-CNCR2820501043>3.0.CO;2-3","article-title":"Relation of adenoma to carcinoma in the gallbladder","volume":"50","author":"Kozuka","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2025.104830_bib39","article-title":"Early carcinoma of the gallbladder, noninvasive carcinoma originating in the Rokitansky-Aschoff sinus: a case report","author":"Kawarada","year":"1986","journal-title":"Am. J. Gastroenterol. Springe Nat."},{"key":"10.1016\/j.critrevonc.2025.104830_bib40","article-title":"Noninvasive carcinoma of the gallbladder arising in localized type adenomyomatosis","author":"Katoh","year":"1988","journal-title":"Am. J. Gastroenterol. Springe Nat. [Internet]"},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104830_bib41","first-page":"825","article-title":"Intramural diverticulosis and cancer of the gallbladder","volume":"11","author":"Paraf","year":"1987","journal-title":"Gastroenterol. Clin. Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib42","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/his.14360","article-title":"Dysplasia and carcinoma of the gallbladder: pathological evaluation, sampling, differential diagnosis and clinical implications","volume":"79","author":"Roa","year":"2021","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib43","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.gtc.2023.10.001","article-title":"Dysplasia and early carcinoma of the gallbladder and bile ducts: terminology, classification, and significance","volume":"53","author":"Adsay","year":"2024","journal-title":"Gastroenterol. Clin."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104830_bib44","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrc1097","article-title":"RAS oncogenes: the first 30 years","volume":"3","author":"Malumbres","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104830_bib45","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/1097-0142(19900901)66:5<930::AID-CNCR2820660519>3.0.CO;2-W","article-title":"Analysis of ras gene mutations in biliary and pancreatic tumors by polymerase chain reaction and direct sequencing","volume":"66","author":"Tada","year":"1990","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104830_bib46","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0092-8674(88)90571-5","article-title":"Most human carcinomas of the exocrine pancreas contain mutant cK-ras genes","volume":"53","author":"Almoguera","year":"1988","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104830_bib47","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/jso.20532","article-title":"K-ras, p53 mutations, and microsatellite instability (MSI) in gallbladder cancer","volume":"93","author":"Saetta","year":"2006","journal-title":"J. Surg. Oncol."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104830_bib48","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1440-1746.2004.03355.x","article-title":"Mutational spectrum of K-ras oncogene among Indian patients with gallbladder cancer","volume":"19","author":"Singh","year":"2004","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib49","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0046-8177(99)90295-2","article-title":"Gallbladder adenomas have molecular abnormalities different from those present in gallbladder carcinomas","volume":"30","author":"Wistuba","year":"1999","journal-title":"Hum. Pathol."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104830_bib50","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1440-1827.1996.tb03618.x","article-title":"APC, K-ras codon 12 mutations and p53 gene expression in carcinoma and adenoma of the gall-bladder suggest two genetic pathways in gall-bladder carcinogenesis","volume":"46","author":"Itoi","year":"1996","journal-title":"Pathol. Int"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104830_bib51","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s12029-019-00283-0","article-title":"Genetic Changes of P53 and kras in gallbladder carcinoma in Kumaon Region of Uttarakhand","volume":"51","author":"Shukla","year":"2020","journal-title":"J. Gastrointest. Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104830_bib52","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/path.1779","article-title":"Amplification and overexpression of c- erb B-2, epidermal growth factor receptor, and c- met in biliary tract cancers","volume":"206","author":"Nakazawa","year":"2005","journal-title":"J. Pathol."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104830_bib53","first-page":"371","article-title":"miR-193a-3p enhanced the chemosensitivity to trametinib in gallbladder carcinoma by targeting KRAS and downregulating ERK Signaling","volume":"38","author":"Yang","year":"2023","journal-title":"Cancer Biother Radio."},{"key":"10.1016\/j.critrevonc.2025.104830_bib54","first-page":"1","article-title":"O\u2019Regan R. The HER2 receptor in breast cancer: pathophysiology, clinical use, and new advances in therapy","volume":"2012","author":"Mitri","year":"2012","journal-title":"Chemother. Res Pr."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib55","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5858\/2010-0454-RAR.1","article-title":"HER2: biology, detection, and clinical implications","volume":"135","author":"Gutierrez","year":"2011","journal-title":"Arch. Pathol. Lab Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib56","first-page":"4","article-title":"A detailed review of EGFR & HER2\/NEU gene expression analysis in Gallbladder cancer","volume":"26","author":"Abeer","year":"2023","journal-title":"JMS Ski"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104830_bib57","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1309\/AJCPQT3ELN2BBCKA","article-title":"Gallbladder cancer in Chile: pathologic characteristics of survival and prognostic factors: analysis of 1,366 cases","volume":"141","author":"Roa","year":"2014","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.critrevonc.2025.104830_bib58","doi-asserted-by":"crossref","DOI":"10.3892\/or.8.5.1127","article-title":"Expression of the c-erb-B2 and p53 protein in gallbladder carcinomas","author":"Kim","year":"2001","journal-title":"Oncol. Rep. [Internet]"},{"key":"10.1016\/j.critrevonc.2025.104830_bib59","article-title":"HER2 positivity is affected by the papillary structure and has a bidirectional prognostic value for gallbladder carcinoma","author":"Chen","year":"2022","journal-title":"Front Genet [Internet]"},{"key":"10.1016\/j.critrevonc.2025.104830_bib60","article-title":"Heterogeneous ERBB gene pathways, their targeted treatment and possible molecular mechanisms of resistance in metastatic gallbladder cancer","author":"Patel","year":"2024","journal-title":"Med J. Armed Forces India [Internet]"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib61","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S2468-1253(22)00335-1","article-title":"Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer refractory to gemcitabine and cisplatin: a multi-institutional phase 2 trial of the Korean Cancer Study Group (KCSG-HB19\u201314)","volume":"8","author":"Lee","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104830_bib62","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrc1609","article-title":"ERBB receptors and cancer: the complexity of targeted inhibitors","volume":"5","author":"Hynes","year":"2005","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib63","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12957-020-01934-4","article-title":"Gallbladder cancer with EGFR mutation and its response to GemOx with erlotinib: a case report and review of literature","volume":"18","author":"Soni","year":"2020","journal-title":"World J. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104830_bib64","first-page":"262","article-title":"Significance of expression of epidermal growth factor (EGF) and its receptor (EGFR) in chronic cholecystitis and gallbladder carcinoma","volume":"22","author":"Zhou","year":"2003","journal-title":"Ai Zheng Aizheng Chin. J. Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104830_bib65","doi-asserted-by":"crossref","first-page":"285","DOI":"10.7150\/ijms.5.285","article-title":"EGFR expression in gallbladder carcinoma in North America","volume":"5","author":"Kaufman","year":"2008","journal-title":"Int J. Med Sci."},{"key":"10.1016\/j.critrevonc.2025.104830_bib66","article-title":"Genomic profiling of gallbladder carcinoma: Targetable mutations and pathways involved","volume":"232","author":"Mishra","year":"2022","journal-title":"Pathol. -Res Pr."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib67","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1186\/1471-2407-10-570","article-title":"Complete response in gallbladder cancer to erlotinib plus gemcitabine does not require mutation of the epidermal growth factor receptor gene: a case report","volume":"10","author":"Mody","year":"2010","journal-title":"BMC Cancer"},{"issue":"21","key":"10.1016\/j.critrevonc.2025.104830_bib68","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1200\/JCO.2010.28.4075","article-title":"Report of a Multicenter Phase II Trial Testing a Combination of Biweekly Bevacizumab and Daily Erlotinib in Patients With Unresectable Biliary Cancer: A Phase II Consortium Study","volume":"28","author":"Lubner","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104830_bib69","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/bjc.2013.801","article-title":"S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma","volume":"110","author":"El-Khoueiry","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104830_bib70","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0046-8177(96)90362-7","article-title":"bcl-2: role in epithelial differentiation and oncogenesis","volume":"27","author":"Lu","year":"1996","journal-title":"Hum. Pathol."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104830_bib71","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1080\/01635581.2022.2059090","article-title":"AFAP1-AS1\/Hsa-miR-15a-5p\/Bcl-2 axis is a potential regulator of cancer cell proliferation and apoptosis in gallbladder carcinoma","volume":"74","author":"Zhu","year":"2022","journal-title":"Nutr. Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104830_bib72","first-page":"237","article-title":"bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis","volume":"55","author":"Sinicrope","year":"1995","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib73","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1245\/s10434-008-0182-x","article-title":"Expression and clinical significance of cell cycle regulatory proteins in gallbladder and extrahepatic bile duct cancer","volume":"16","author":"Kim","year":"2009","journal-title":"Ann. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib74","article-title":"\u03b2-catenin activation down-regulates cell-cell junction-related genes and induces epithelial-to-mesenchymal transition in colorectal cancers","volume":"9","author":"Kim","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2025.104830_bib75","article-title":"Genetic mutational analysis of \u03b2-catenin gene affecting GSK-3\u03b2 phosphorylation plays a role in gallbladder carcinogenesis: Results from a case control study","volume":"23","author":"Dixit","year":"2020","journal-title":"Cancer Treat. Res Commun."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104830_bib76","first-page":"321","article-title":"Frequent beta-catenin alteration in gallbladder carcinomas","volume":"22","author":"Kimura","year":"2003","journal-title":"J. Exp. Clin. Cancer Res CR"},{"issue":"15","key":"10.1016\/j.critrevonc.2025.104830_bib77","doi-asserted-by":"crossref","first-page":"16076","DOI":"10.1002\/cam4.6261","article-title":"Mutational spectrum for guiding the decision of adjuvant treatment in patients with resected biliary tract carcinoma","volume":"12","author":"Li","year":"2023","journal-title":"Cancer Med"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104830_bib78","first-page":"1103","article-title":"BRAF in malignant melanoma progression and metastasis: potentials and challenges","volume":"10","author":"Alqathama","year":"2020","journal-title":"Am. J. Cancer Res"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104830_bib79","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.3390\/cancers11081197","article-title":"Targeting oncogenic BRAF: past, present, and future","volume":"11","author":"Zaman","year":"2019","journal-title":"Cancers"},{"issue":"22","key":"10.1016\/j.critrevonc.2025.104830_bib80","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1038\/sj.onc.1210421","article-title":"MAP kinase signalling pathways in cancer","volume":"26","author":"Dhillon","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2025.104830_bib81","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00428-004-1046-9","article-title":"Mutational analysis of BRAF in gallbladder carcinomas in association with K-ras and p53 mutations and microsatellite instability","volume":"445","author":"Saetta","year":"2004","journal-title":"Virchows Arch."},{"issue":"23","key":"10.1016\/j.critrevonc.2025.104830_bib82","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1158\/1078-0432.CCR-23-1926","article-title":"Comparative genomic analysis and clinical outcomes of BRAF-mutated advanced biliary tract cancers","volume":"29","author":"Tang","year":"2023","journal-title":"Clin. Cancer Res"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104830_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2023.100301","article-title":"Diagnostic utility of next-generation sequencing in circulating free dna and a comparison with matched tissue in gallbladder carcinoma","volume":"104","author":"Mishra","year":"2024","journal-title":"Lab Invest"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104830_bib84","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/jgh.12505","article-title":"Clinicopathological and prognostic significances of EGFR, KRAS and BRAF mutations in biliary tract carcinomas in T aiwan","volume":"29","author":"Chang","year":"2014","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib85","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41571-021-00549-2","article-title":"The MYC oncogene - the grand orchestrator of cancer growth and immune evasion","volume":"19","author":"Dhanasekaran","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib86","first-page":"19","article-title":"Gene amplification of myc and its coamplification with ERBB2 and EGFR in gallbladder adenocarcinoma","volume":"29","author":"Ooi","year":"2009","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104830_bib87","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10238-014-0311-8","article-title":"Deregulation of MYC and TP53 through genetic and epigenetic alterations in gallbladder carcinomas","volume":"15","author":"Ishak","year":"2015","journal-title":"Clin. Exp. Med"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104830_bib88","first-page":"249","article-title":"Expression of p53 in gallbladder carcinoma and in dysplastic and metaplastic lesions of the surrounding mucosa","volume":"92","author":"Billo","year":"2000","journal-title":"Pathologica"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104830_bib89","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S1072-7515(01)01012-2","article-title":"Association of p53, p16, and vascular endothelial growth factor protein expressions with the prognosis and metastasis of gallbladder cancer","volume":"193","author":"Quan","year":"2001","journal-title":"J. Am. Coll. Surg."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104830_bib90","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jhep.2020.11.033","article-title":"Integrative molecular characterisation of gallbladder cancer reveals micro-environment-associated subtypes","volume":"74","author":"Nepal","year":"2021","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib91","first-page":"26","article-title":"Metaplastic changes in chronic cholecystitis: implications for early diagnosis and surgical intervention to prevent the gallbladder metaplasia-dysplasia-carcinoma sequence","volume":"6","author":"Seretis","year":"2014","journal-title":"J. Clin. Med Res"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib92","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13000-024-01550-w","article-title":"Utility of IMP3, p53, and S100P immunohistochemical stains in distinguishing reactive atypia from dysplasia in cholecystectomy specimens","volume":"19","author":"Sica","year":"2024","journal-title":"Diagn. Pathol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104830_bib93","first-page":"297","article-title":"Mutations of p53 in gallbladder carcinomas in high-incidence areas of Japan and Chile","volume":"7","author":"Yokoyama","year":"1998","journal-title":"Cancer Epidemiol. Biomark. Prev. Publ. Am. Assoc. Cancer Res Cosponsored Am. Soc. Prev. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104830_bib94","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S1665-2681(19)32065-4","article-title":"TP53 abnormalities are frequent and early events in the sequential pathogenesis of gallbladder carcinoma","volume":"4","author":"Moreno","year":"2005","journal-title":"Ann. Hepatol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104830_bib95","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0165-4608(83)90133-4","article-title":"Adenocarcinoma of the gallbladder: chromosome abnormalities in a genetic form of cancer","volume":"8","author":"Hecht","year":"1983","journal-title":"Cancer Genet Cytogenet"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104830_bib96","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/hep.31585","article-title":"Epigenome-wide analysis of methylation changes in the sequence of gallstone disease, dysplasia, and gallbladder cancer","volume":"73","author":"Br\u00e4gelmann","year":"2021","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104830_bib97","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3892\/or.2013.2511","article-title":"Anticancer activity of oncolytic adenoviruses carrying p53 is augmented by 11R in gallbladder cancer cell lines in vitro and in vivo","volume":"30","author":"Wang","year":"2013","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib98","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1634\/theoncologist.2011-0386","article-title":"Frequent Mutation of Isocitrate Dehydrogenase (IDH)1 and IDH2 in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping","volume":"17","author":"Borger","year":"2012","journal-title":"Oncologist"},{"issue":"3_","key":"10.1016\/j.critrevonc.2025.104830_bib99","article-title":"Tumor profiling of biliary tract carcinomas to reveal distinct molecular alterations and potential therapeutic targets","volume":"33","author":"Holcombe","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"3_","key":"10.1016\/j.critrevonc.2025.104830_bib100","article-title":"Comprehensive genomic profiling of biliary tract cancers to reveal tumor-specific differences and genomic alterations","volume":"33","author":"Ross","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib101","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13000-015-0381-2","article-title":"Inactivation of tumor suppressor gene pten in early and advanced gallbladder cancer","volume":"10","author":"Roa","year":"2015","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.critrevonc.2025.104830_bib102","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ctrv.2018.11.001","article-title":"Targeting the PI3K\/AKT\/mTOR pathway in biliary tract cancers: A review of current evidences and future perspectives","volume":"72","author":"Corti","year":"2019","journal-title":"Cancer Treat. Rev."},{"issue":"22","key":"10.1016\/j.critrevonc.2025.104830_bib103","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.3390\/cancers13225671","article-title":"Molecular targets and emerging therapies for advanced gallbladder cancer","volume":"13","author":"Canale","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib104","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s12029-017-9919-8","article-title":"Epigenetic downregulation of PTEN in gallbladder cancer","volume":"48","author":"Tekcham","year":"2017","journal-title":"J. Gastrointest. Cancer"},{"key":"10.1016\/j.critrevonc.2025.104830_bib105","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.canlet.2020.11.016","article-title":"PTEN deficiency facilitates the therapeutic vulnerability to proteasome inhibitor bortezomib in gallbladder cancer","volume":"501","author":"Jiang","year":"2021","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104830_bib106","first-page":"81","article-title":"A phase II trial of the proteasome inhibitor bortezomib in patients with advanced biliary tract cancers","volume":"13","author":"Denlinger","year":"2014","journal-title":"Clin. Colorectal Cancer"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104830_bib107","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/cncr.33364","article-title":"Phase 2 study of copanlisib in combination with gemcitabine and cisplatin in advanced biliary tract cancers","volume":"127","author":"Tan","year":"2021","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib108","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.gene.2016.04.047","article-title":"Non-coding RNAs as emerging molecular targets of gallbladder cancer","volume":"588","author":"Tekcham","year":"2016","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib109","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.prp.2015.11.010","article-title":"Complex APC germline mutation associated metaplasia and intraepithelial neoplasia (CAM-IEN) of the gallbladder","volume":"212","author":"B\u00f6ger","year":"2016","journal-title":"Pathol. -Res Pr."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104830_bib110","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/SLA.0000000000000495","article-title":"Sequential occurrence of preneoplastic lesions and accumulation of loss of heterozygosity in patients with gallbladder stones suggest causal association with gallbladder cancer","volume":"260","author":"Jain","year":"2014","journal-title":"Ann. Surg."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104830_bib111","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrm3567","article-title":"Molecular mechanisms underlying RB protein function","volume":"14","author":"Dick","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104830_bib112","first-page":"49","article-title":"Molecular genetics changes in gallbladder carcinoma","volume":"5","author":"Verma","year":"2020","journal-title":"Int J. Mol. Immuno Oncol."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104830_bib113","first-page":"4096","article-title":"Overexpression of retinoblastoma protein predicts decreased survival and correlates with loss of p16INK4 protein in gallbladder carcinomas","volume":"6","author":"Shi","year":"2000","journal-title":"Clin. Cancer Res J. Am. Assoc. Cancer Res"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104830_bib114","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.7314\/APJCP.2013.14.5.2711","article-title":"Cyclin D1, retinoblastoma and p16 protein expression in carcinoma of the gallbladder","volume":"14","author":"Srivastava","year":"2013","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104830_bib115","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/jclinpath-2018-205095","article-title":"Smad4\/DPC4","volume":"71","author":"McCarthy","year":"2018","journal-title":"J. Clin. Pathol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104830_bib116","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/annonc\/10.suppl_4.S56","article-title":"DPC4\/SMAD4 gene alterations in human cancer, and their functional implications","volume":"10","author":"Schutte","year":"1999","journal-title":"Ann. Oncol. J. Eur. Soc. Med Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104830_bib117","first-page":"481","article-title":"Frequency of loss expression of the DPC4 protein in various locations of biliary tract carcinoma","volume":"36","author":"Tang","year":"2002","journal-title":"Zhonghua Yu Fang. Yi Xue Za Zhi"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104830_bib118","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s00268-004-7447-8","article-title":"Immunohistochemical Study of DPC4 and p53 Proteins in Gallbladder and Bile Duct Cancers","volume":"28","author":"Chuang","year":"2004","journal-title":"World J. Surg."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104830_bib119","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1007\/s11030-021-10210-w","article-title":"Structural based screening of potential inhibitors of SMAD4: a step towards personalized medicine for gall bladder and other associated cancers","volume":"25","author":"Kumar","year":"2021","journal-title":"Mol. Divers"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104830_bib120","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s11060-019-03333-6","article-title":"Analysis of CDKN2A gene alterations in recurrent and non-recurrent meningioma","volume":"145","author":"Guyot","year":"2019","journal-title":"J. Neurooncol"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib121","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41698-022-00327-y","article-title":"Comprehensive clinicopathological and genomic profiling of gallbladder cancer reveals actionable targets in half of patients","volume":"6","author":"de Bitter","year":"2022","journal-title":"NPJ Precis Oncol."},{"key":"10.1016\/j.critrevonc.2025.104830_bib122","article-title":"Identification of Altered Genes in Gallbladder Cancer as Potential Driver Mutations for Diagnostic and Prognostic Purposes: A Computational Approach","volume":"19","author":"D\u2019Afonseca","year":"2020","journal-title":"Cancer Inf."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib123","first-page":"9644466","article-title":"[Retracted] Expression Profile and Prognostic Values of CDH Family Members in Lung Adenocarcinoma","volume":"2022","author":"Li","year":"2022","journal-title":"Dis. Markers"},{"key":"10.1016\/j.critrevonc.2025.104830_bib124","doi-asserted-by":"crossref","first-page":"10477","DOI":"10.2147\/CMAR.S208818","article-title":"CDH1 (E-Cadherin) mutation and gastric cancer: genetics, molecular mechanisms and guidelines for management","volume":"11","author":"Shenoy","year":"2019","journal-title":"Cancer Manag Res"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104830_bib125","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00428-010-0908-6","article-title":"Role of E-cadherin gene in gall bladder cancer and its precursor lesions","volume":"456","author":"Priya","year":"2010","journal-title":"Virchows Arch."},{"issue":"18","key":"10.1016\/j.critrevonc.2025.104830_bib126","doi-asserted-by":"crossref","first-page":"6126","DOI":"10.1158\/1078-0432.CCR-04-0579","article-title":"Aberrant promoter hypermethylation of multiple genes in gallbladder carcinoma and chronic cholecystitis","volume":"10","author":"Takahashi","year":"2004","journal-title":"Clin. Cancer Res"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104830_bib127","first-page":"49","article-title":"Molecular genetics changes in gallbladder carcinoma","volume":"5","author":"Verma","year":"2020","journal-title":"Int J. Mol. Immuno Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104830_bib128","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00535-005-1752-3","article-title":"Promoter methylation profile in gallbladder cancer","volume":"41","author":"Roa","year":"2006","journal-title":"J. Gastroenterol."},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104830_bib129","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.humpath.2005.08.025","article-title":"Breast cancer in an MSH2 gene mutation carrier","volume":"36","author":"Westenend","year":"2005","journal-title":"Hum. Pathol."},{"issue":"22","key":"10.1016\/j.critrevonc.2025.104830_bib130","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1001\/jama.2011.743","article-title":"Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in lynch syndrome","volume":"305","author":"Bonadona","year":"2011","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib131","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mrrev.2011.06.002","article-title":"Candidate gene studies in gallbladder cancer: a systematic review and meta-analysis","volume":"728","author":"Srivastava","year":"2011","journal-title":"Mutat. Res Mutat. Res"},{"key":"10.1016\/j.critrevonc.2025.104830_bib132","unstructured":"Hardman: Involvement of mammalian MLH1 in the apoptotic\u2026 - Google Scholar [Internet]. [cited 2024 Nov 22]. Available from: \u3008https:\/\/scholar.google.com\/scholar_lookup?&title=Involvement%20of%20mammalian%20MLH1%20in%20the%20apoptotic%20response%20to%20peroxide-induced%20oxidative%20stress&journal=Cancer%20Res&volume=61&pages=1392-1397&publication_year=2001&author=Hardman%2CRA&author=Afshari%2CCA&author=Barrett%2CJC\u3009."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104830_bib133","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00439-006-0148-7","article-title":"Association between the MLH1 gene and longevity","volume":"119","author":"Kim","year":"2006","journal-title":"Hum. Genet"},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104830_bib134","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.3390\/genes14112060","article-title":"MLH1 promoter methylation could be the second hit in lynch syndrome carcinogenesis","volume":"14","author":"Carnevali","year":"2023","journal-title":"Genes"},{"key":"10.1016\/j.critrevonc.2025.104830_bib135","article-title":"Implementation of BRCA mutations testing in formalin-fixed paraffin-embedded (FFPE) samples of different cancer types","volume":"243","author":"Zannini","year":"2023","journal-title":"Pathol. Res Pr."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib136","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000527525","article-title":"Clinical implications of BRCA mutations in advanced biliary tract cancer","volume":"101","author":"Kim","year":"2023","journal-title":"Oncology"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104830_bib137","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2020-000682","article-title":"Molecular profile of BRCA-mutated biliary tract cancers","volume":"5","author":"Spizzo","year":"2020","journal-title":"ESMO Open"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104830_bib138","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/jnci\/92.10.795","article-title":"Cancer risk and the ATM gene: a continuing debate","volume":"92","author":"Khanna","year":"2000","journal-title":"JNCI J. Natl. Cancer Inst."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104830_bib139","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1634\/theoncologist.2019-0498","article-title":"Effectiveness of olaparib treatment in a patient with gallbladder cancer with an ATM-inactivating mutation","volume":"25","author":"Zhang","year":"2020","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104830_bib140","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3390\/genes12020313","article-title":"A novel ATM pathogenic variant in an italian woman with gallbladder cancer","volume":"12","author":"De Paolis","year":"2021","journal-title":"Genes"},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104830_bib141","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1053\/hupa.2002.129415","article-title":"Alterations of the p16INK4a\/Rb\/cyclin-D1 pathway in vulvar carcinoma, vulvar intraepithelial neoplasia, and lichen sclerosus","volume":"33","author":"Lerma","year":"2002","journal-title":"Hum. Pathol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104830_bib142","first-page":"84","article-title":"Influence of HPV16 on expression of Rb, p16 and cyclin D1 in oral epithelial cell","volume":"37","author":"Sdek","year":"2002","journal-title":"Zhonghua Kou Qiang Yi Xue Za Zhi Zhonghua Kouqiang Yixue Zazhi Chin. J. Stomatol"},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104830_bib143","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1038\/sj.leu.2402609","article-title":"Alterations of the cyclin D1\/pRb\/p16INK4A pathway in multiple myeloma","volume":"16","author":"Kr\u00e4mer","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2025.104830_bib144","unstructured":"Varol U., Kucukzeybek Y., Alacacioglu A., Somali I., Altun Z., Tarhan M.O. BRCA genes: BRCA 1 and BRCA 2.J BUON. 2018 Jul-Aug;23(4):862-866."},{"key":"10.1016\/j.critrevonc.2025.104830_bib145","unstructured":"Hui A.M., Li X., Shi Y.Z., Torzilli G., Takayama T., Makuuchi M. p27Kip1 expression in normal epithelia, precancerous lesions, and carcinomas of the gallbladder: Association with cancer progression and prognosis. [cited 2024 Nov 23]; Available from: \u3008https:\/\/aasldpubs.onlinelibrary.wiley.com\/doi\/10.1053\/he.2000.6127\u3009."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib146","first-page":"93","article-title":"Cyclin E overexpression in human gallbladder carcinomas","volume":"6","author":"Eguchi","year":"1999","journal-title":"Oncol. Rep."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104830_bib147","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3748\/wjg.v11.i5.744","article-title":"Association of cyclin D1, p16 and retinoblastoma protein expressions with prognosis and metastasis of gallbladder carcinoma","volume":"11","author":"Ma","year":"2005","journal-title":"World J. Gastroenterol. WJG"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104830_bib148","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.yexmp.2011.06.004","article-title":"The risk factor of gallbladder cancer: hyperplasia of mucous epithelium caused by gallstones associates with p16\/CyclinD1\/CDK4 pathway","volume":"91","author":"Feng","year":"2011","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.critrevonc.2025.104830_bib149","unstructured":"Altieri: Survivin apoptosis: an interloper between\u2026 - Google Scholar [Internet]. [cited 2024 Nov 25]. Available from: \u3008https:\/\/scholar.google.com\/scholar_lookup?title=Survivin+apoptosis%3a+an+interloper+between+cell+death+and+cell+proliferation+in+cancer&publication_year=1999&author=DC+Altieri&author=PC+Marchisio\u3009."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104830_bib150","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4103\/0971-5916.159250","article-title":"Survivin: a molecular biomarker in cancer","volume":"141","author":"Jaiswal","year":"2015","journal-title":"Indian J. Med Res"},{"key":"10.1016\/j.critrevonc.2025.104830_bib151","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4103\/jcar.JCar_4_21","article-title":"Expression of Human epidermal growth factor receptor 2, survivin, enhancer of zeste homolog -2, cyclooxygenase-2, p53 and p16 molecular markers in Gall bladder carcinoma","volume":"20","author":"Gupta","year":"2021","journal-title":"J. Carcinog."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104830_bib152","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/(SICI)1097-0142(19990115)85:2<318::AID-CNCR8>3.0.CO;2-S","article-title":"Association of Bcl-2 protein expression with gallbladder carcinoma differentiation and progression and its relation to apoptosis","volume":"85","author":"Mikami","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2025.104830_bib153","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.3389\/fimmu.2019.01078","article-title":"Cell adhesion molecules and their roles and regulation in the immune and tumor microenvironment","volume":"10","author":"Harjunp\u00e4\u00e4","year":"2019","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib154","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s004410100390","article-title":"The role of E-cadherin in the differentiation of gallbladder cancer cells","volume":"306","author":"Mukai","year":"2001","journal-title":"Cell Tissue Res"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104830_bib155","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1177\/002215540405200504","article-title":"An Immunohistochemical Study of the Expression of Adhesion Molecules in Gallbladder Lesions","volume":"52","author":"Choi","year":"2004","journal-title":"J. Histochem Cytochem"},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104830_bib156","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1517\/14712598.8.11.1749","article-title":"L1-CAM in cancerous tissues","volume":"8","author":"Gavert","year":"2008","journal-title":"Expert Opin. Biol. Ther."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104830_bib157","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.humpath.2006.03.014","article-title":"Expression profile analysis in multiple human tumors identifies L1 (CD171) as a molecular marker for differential diagnosis and targeted therapy","volume":"37","author":"Huszar","year":"2006","journal-title":"Hum. Pathol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104830_bib158","first-page":"945","article-title":"The cell adhesion molecule L1 promotes gallbladder carcinoma progression in vitro and in vivo","volume":"25","author":"Jung","year":"2011","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib159","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s12032-022-01874-x","article-title":"Fibrinogen promotes gallbladder cancer cell metastasis and extravasation by inducing ICAM1 expression","volume":"40","author":"Jiang","year":"2022","journal-title":"Med Oncol."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104830_bib160","doi-asserted-by":"crossref","first-page":"6898","DOI":"10.3390\/ijms24086898","article-title":"Clinicopathological Significance of Cell Adhesion Molecule 4 Expression in Gallbladder Cancer and Its Prognostic Role","volume":"24","author":"Bang","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104830_bib161","first-page":"261","article-title":"MUC1 and MUC4: Switching the Emphasis from Large to Small","volume":"26","author":"Albrecht","year":"2011","journal-title":"Cancer Biother Radio."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib162","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jso.22055","article-title":"Expressive levels of MUC1 and MUC5AC and their clinicopathologic significances in the benign and malignant lesions of gallbladder","volume":"105","author":"Xiong","year":"2012","journal-title":"J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib163","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/1477-7819-10-224","article-title":"Prognostic significance of muc4 expression in gallbladder carcinoma","volume":"10","author":"Lee","year":"2012","journal-title":"World J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib164","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jss.2008.01.032","article-title":"Estrogen receptor \u03b1, estrogen receptor \u03b2, and progesterone receptor as possible prognostic factor in radically resected gallbladder carcinoma","volume":"152","author":"Park","year":"2009","journal-title":"J. Surg. Res"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib165","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2020.112118","article-title":"MUC16C-terminal binding with ALDOC disrupts the ability of ALDOC to sense glucose and promotes gallbladder carcinoma growth","volume":"394","author":"Fan","year":"2020","journal-title":"Exp. Cell Res"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104830_bib166","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.18632\/oncotarget.3306","article-title":"Somatic microsatellite variability as a predictive marker for colorectal cancer and liver cancer progression","volume":"6","author":"Vaksman","year":"2015","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104830_bib167","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1007\/s00432-019-03053-4","article-title":"Correlations between microsatellite instability and the biological behaviour of tumours","volume":"145","author":"Yang","year":"2019","journal-title":"J. Cancer Res Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib168","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00535-004-1497-4","article-title":"Microsatellite instability in preneoplastic and neoplastic lesions of the gallbladder","volume":"40","author":"Roa","year":"2005","journal-title":"J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib169","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3748\/wjg.14.70","article-title":"Genetic changes of p53, K-ras, and microsatellite instability in gallbladder carcinoma in high-incidence areas of Japan and Hungary","volume":"14","author":"Nagahashi","year":"2008","journal-title":"World J. Gastroenterol. WJG"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104830_bib170","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1111\/j.1572-0241.1999.01155.x","article-title":"Gene mutations of K-ras in gallbladder mucosae and gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct","volume":"94","author":"Hanada","year":"1999","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib171","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13000-019-0813-5","article-title":"Low frequency of mismatch repair deficiency in gallbladder cancer","volume":"14","author":"Goeppert","year":"2019","journal-title":"Diagn. Pathol."},{"issue":"21","key":"10.1016\/j.critrevonc.2025.104830_bib172","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.3390\/cancers13215257","article-title":"Gallbladder Cancer: Current Insights in Genetic Alterations and Their Possible Therapeutic Implications","volume":"13","author":"Kuipers","year":"2021","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104830_bib173","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3390\/metabo14050273","article-title":"Environmental and Metabolic Risk Factors Linked to Gallbladder Dysplasia","volume":"14","author":"Bojan","year":"2024","journal-title":"Metabolites"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104830_bib174","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1006\/jsre.2001.6297","article-title":"Loss of heterozygosity of chromosome 16q in gallbladder carcinoma","volume":"102","author":"Matsuo","year":"2002","journal-title":"J. Surg. Res"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104830_bib175","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jhep.2022.09.025","article-title":"Hereditary cancer variants and homologous recombination deficiency in biliary tract cancer","volume":"78","author":"Okawa","year":"2023","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104830_bib176","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/01.MXE.0000415225.85003.47","article-title":"Genetic polymorphism studies in humans","volume":"1","author":"Ismail","year":"2012","journal-title":"Middle East J. Med Genet"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104830_bib177","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1111\/cas.14344","article-title":"Estrogen-related receptor-\u03b1 promotes gallbladder cancer development by enhancing the transcription of Nectin-4","volume":"111","author":"Wang","year":"2020","journal-title":"Cancer Sci."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104830_bib178","first-page":"41","article-title":"Expression and clinicopathological significance of estrogen and progesterone receptors in gallbladder cancer","volume":"5","author":"Gupta","year":"2012","journal-title":"Gastrointest. Cancer Res GCR"},{"key":"10.1016\/j.critrevonc.2025.104830_bib179","doi-asserted-by":"crossref","unstructured":"Zhai G., Yan K., Ji X., Xu W., Yang J., Xiong F., et al. LAPTM4B allele* 2 is a marker of poor prognosis for gallbladder carcinoma. 2012 [cited 2024 Nov 27]; Available from: \u3008https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0045290\u3009.","DOI":"10.1371\/journal.pone.0045290"},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104830_bib180","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1111\/jgh.12278","article-title":"Variants in CCK and CCKAR genes to susceptibility to biliary tract cancers and stones: A population-based study in S hanghai, C hina","volume":"28","author":"Xu","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104830_bib181","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1111\/j.1478-3231.2012.02822.x","article-title":"Higher risk of matrix metalloproteinase ( MMP -2, 7, 9) and tissue inhibitor of metalloproteinase ( TIMP -2) genetic variants to gallbladder cancer","volume":"32","author":"Sharma","year":"2012","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104830_bib182","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/172460081002500203","article-title":"Evidence that Genetic Variants of Metabolic Detoxication and Cell Cycle Control Are Not Related to Gallbladder Cancer Risk in Chilean Women","volume":"25","author":"Tsuchiya","year":"2010","journal-title":"Int J. Biol. Markers"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104830_bib183","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061456","article-title":"Roles of ApoB-100 gene polymorphisms and the risks of gallstones and gallbladder cancer: a meta-analysis","volume":"8","author":"Gong","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2025.104830_bib184","article-title":"Missense allele of a single nucleotide polymorphism rs2294008 attenuated antitumor effects of prostate stem cell antigen in gallbladder cancer cells","author":"Ono","year":"2013","journal-title":"J. Carcinog. [Internet]"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104830_bib185","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.prp.2011.05.010","article-title":"Overexpression of EZH2 and loss of expression of PTEN is associated with invasion, metastasis, and poor progression of gallbladder adenocarcinoma","volume":"207","author":"Liu","year":"2011","journal-title":"Pathol. -Res Pr."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104830_bib186","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1080\/01635581.2019.1661503","article-title":"Role of Glutathione -S- Transferases in Gallbladder Cancer and Cholelithiasis Susceptibility and Meta-Analysis","volume":"72","author":"Malik","year":"2020","journal-title":"Nutr. Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104830_bib187","first-page":"376","article-title":"Cancer epigenetics in clinical practice","volume":"73","author":"Davalos","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.critrevonc.2025.104830_bib188","series-title":"Epigenetics in Allergy and Autoimmunity [Internet]","first-page":"3","article-title":"Epigenetics in Health and Disease","author":"Zhang","year":"2020"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104830_bib189","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nrg2005","article-title":"Cancer epigenomics: DNA methylomes and histone-modification maps","volume":"8","author":"Esteller","year":"2007","journal-title":"Nat. Rev. Genet"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib190","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.canlet.2006.09.019","article-title":"Frequent epigenetic inactivation of chromosome 3p candidate tumor suppressor genes in gallbladder carcinoma","volume":"250","author":"Riquelme","year":"2007","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib191","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.surg.2010.12.010","article-title":"Overexpression of LAPTM4B-35 attenuates epirubucin-induced apoptosis of gallbladder carcinoma GBC-SD cells","volume":"150","author":"Zhou","year":"2011","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104830_bib192","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s10620-023-08216-5","article-title":"Clinical Significance of Frequently Down-Regulated Phosphatidylethanolamine-Binding Protein-1 in Gallbladder Cancer","volume":"69","author":"Bharti","year":"2024","journal-title":"Dig. Dis. Sci."},{"issue":"16","key":"10.1016\/j.critrevonc.2025.104830_bib193","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202308531","article-title":"DNMT3A Cooperates with YAP\/TAZ to drive gallbladder cancer metastasis","volume":"11","author":"Xu","year":"2024","journal-title":"Adv. Sci."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104830_bib194","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrc1279","article-title":"The history of cancer epigenetics","volume":"4","author":"Feinberg","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib195","first-page":"80","article-title":"KAT5 silencing induces apoptosis of GBC-SD cells through p38MAPK-mediated upregulation of cleaved Casp9","volume":"7","author":"Feng","year":"2014","journal-title":"Int J. Clin. Exp. Pathol."},{"key":"10.1016\/j.critrevonc.2025.104830_bib196","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.130426","article-title":"Decoding the role of long non-coding RNAs in gallbladder cancer pathogenesis: a review focus on signaling pathways interplay","author":"Doghish","year":"2024","journal-title":"Int J. Biol. Macromol."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104830_bib197","doi-asserted-by":"crossref","first-page":"6985","DOI":"10.1007\/s13277-015-3412-4","article-title":"MicroRNA signatures in total peripheral blood of gallbladder cancer patients","volume":"36","author":"Li","year":"2015","journal-title":"Tumor Biol."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104830_bib198","first-page":"1849","article-title":"miR-1 and miR-145 act as tumor suppressor microRNAs in gallbladder cancer","volume":"7","author":"Letelier","year":"2014","journal-title":"Int J. Clin. Exp. Pathol."},{"key":"10.1016\/j.critrevonc.2025.104830_bib199","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ijsu.2018.03.053","article-title":"DNA methylation as an epigenetic regulator of gallbladder cancer: An overview","volume":"53","author":"Muhammad","year":"2018","journal-title":"Int J. Surg."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104830_bib200","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.3748\/wjg.v22.i5.1787","article-title":"MicroRNA aberrations: an emerging field for gallbladder cancer management","volume":"22","author":"Chandra","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.critrevonc.2025.104830_bib201","article-title":"Circulating microRNAs in gallbladder cancer: is serum assay of diagnostic value?","volume":"242","author":"Srivastava","year":"2023","journal-title":"Pathol. -Res Pr."},{"key":"10.1016\/j.critrevonc.2025.104830_bib202","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.149724","article-title":"Metabolomics and miRNA profiling reveals feature of gallbladder cancer-derived biliary extracellular vesicles","volume":"705","author":"Kong","year":"2024","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.critrevonc.2025.104830_bib203","doi-asserted-by":"crossref","DOI":"10.1016\/j.omton.2024.200765","article-title":"MicroRNA-34a-5p: a pivotal therapeutic target in gallbladder cancer","author":"Oda","year":"2024","journal-title":"Mol. Ther. Oncol. [Internet]"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib204","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cell.2019.02.032","article-title":"Genomic analysis in the age of human genome sequencing","volume":"177","author":"Lappalainen","year":"2019","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104830_bib205","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/nrg3455","article-title":"Sequencing studies in human genetics: design and interpretation","volume":"14","author":"Goldstein","year":"2013","journal-title":"Nat. Rev. Genet"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104830_bib206","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.5213\/inj.1632742.371","article-title":"Trends in Next-Generation Sequencing and a New Era for Whole Genome Sequencing","volume":"20","author":"Park","year":"2016","journal-title":"Int Neurourol. J."},{"key":"10.1016\/j.critrevonc.2025.104830_bib207","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.mrrev.2018.08.003","article-title":"Genetic landscape of gallbladder cancer: Global overview","volume":"778","author":"Mehrotra","year":"2018","journal-title":"Mutat. Res Mutat. Res"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104830_bib208","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/ng.3030","article-title":"Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway","volume":"46","author":"Li","year":"2014","journal-title":"Nat. Genet"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104830_bib209","first-page":"495","article-title":"Targeted gene sequencing of gallbladder carcinoma identifies high-impact somatic and rare germline mutations","volume":"14","author":"Yadav","year":"2017","journal-title":"Cancer Genom. Proteom."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104830_bib210","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41576-019-0150-2","article-title":"RNA sequencing: the teenage years","volume":"20","author":"Stark","year":"2019","journal-title":"Nat. Rev. Genet"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104830_bib211","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.694","article-title":"Single-cell RNA sequencing technologies and applications: A brief overview","volume":"12","author":"Jovic","year":"2022","journal-title":"Clin. Transl. Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib212","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s13045-020-01005-x","article-title":"RNA sequencing: new technologies and applications in cancer research","volume":"13","author":"Hong","year":"2020","journal-title":"J. Hematol. OncolJ Hematol. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104830_bib213","doi-asserted-by":"crossref","unstructured":"Yang S., Qin L., Wu P., Liu Y., Zhang Y., Mao B., et al. RNA sequencing revealed the multi-stage transcriptome transformations during the development of gallbladder cancer associated with chronic inflammation. PLOS ONE. 2023b;18(3):e0283770. All the datasets generated and analysed during the current study are available from the GEO repository (accession number, GSE202479) (\u3008https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE202479\u3009).","DOI":"10.1371\/journal.pone.0283770"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104830_bib214","doi-asserted-by":"crossref","first-page":"6395","DOI":"10.1007\/s11033-022-07448-4","article-title":"Unravelling of the comparative Transcriptomic Profile of Gallbladder Cancer using mRNA sequencing","volume":"49","author":"Dixit","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.critrevonc.2025.104830_bib215","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.2147\/IJGM.S442379","article-title":"Identification of long noncoding RNAs expression profiles between gallstone and gallbladder cancer using next-generation sequencing analysis","volume":"17","author":"Wang","year":"2024","journal-title":"Int J. Gen. Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib216","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-44767-3","article-title":"Next generation sequencing uncovers multiple miRNAs associated molecular targets in gallbladder cancer patients","volume":"13","author":"Saxena","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2025.104830_bib217","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s11033-025-10607-y","article-title":"Bioprospecting potential genetic biomarkers of gallbladder cancer","volume":"52","author":"Dixit","year":"2025","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.critrevonc.2025.104830_bib218","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.115138","article-title":"Small-RNA sequencing reveals potential serum biomarkers for gallbladder cancer: results from a three-stage collaborative study of large European prospective cohorts","volume":"214","author":"Blandino","year":"2025","journal-title":"Eur. J. Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104830_bib219","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ccell.2025.02.011","article-title":"Multimodal integration of liquid biopsy and radiology for the noninvasive diagnosis of gallbladder cancer and benign disorders","volume":"43","author":"Yang","year":"2025","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104830_bib220","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1080\/15384047.2018.1456604","article-title":"Liquid biopsy of bile for the molecular diagnosis of gallbladder cancer","volume":"19","author":"Kinugasa","year":"2018","journal-title":"Cancer Biol. Ther."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104830_bib221","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.jhep.2024.10.020","article-title":"Concordance of ctDNA and tissue genomic profiling in advanced biliary tract cancer","volume":"82","author":"Hwang","year":"2025","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104830_bib222","doi-asserted-by":"crossref","first-page":"143","DOI":"10.25259\/IJMR_1651_2024","article-title":"Diagnostic accuracy of cfDNA levels in gallbladder cancer: A study using qPCR & threshold evaluation","volume":"161","author":"Jindal","year":"2025","journal-title":"Indian J. Med Res"},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104830_bib223","first-page":"3429","article-title":"EpCAM-based flow cytometric detection of circulating tumor cells in gallbladder carcinoma cases","volume":"18","author":"Awasthi","year":"2017","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib224","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3390\/cancers14010233","article-title":"Circulating cell-free DNA-based comprehensive molecular analysis of biliary tract cancers using next-generation sequencing","volume":"14","author":"Csoma","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104830_bib225","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1007\/s11010-023-04667-6","article-title":"Molecular aspects of ABCB1 and ABCG2 in gallbladder cancer and its clinical relevance","volume":"478","author":"Nimisha","year":"2023","journal-title":"Mol. Cell Biochem"},{"key":"10.1016\/j.critrevonc.2025.104830_bib226","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2019.101643","article-title":"ABCB1\/4 gallbladder cancer risk variants identified in India also show strong effects in Chileans","volume":"65","author":"Boekstegers","year":"2020","journal-title":"Cancer Epidemiol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104830_bib227","doi-asserted-by":"crossref","first-page":"31","DOI":"10.21037\/cco.2019.08.13","article-title":"Gallbladder cancer: epidemiology and genetic risk associations","volume":"8","author":"Schmidt","year":"2019","journal-title":"Chin. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104830_bib228","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1002\/ijc.31916","article-title":"ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancer","volume":"144","author":"Iyer","year":"2019","journal-title":"Int J. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib229","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1186\/s12876-024-03485-4","article-title":"Epidermal Growth Factor Receptor (EGFR) and SMAD4 negatively correlated in the progression of gallbladder cancer in Eastern Indian patients","volume":"24","author":"Choudhury","year":"2024","journal-title":"BMC Gastroenterol."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104830_bib230","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1002\/(SICI)1097-0142(19961115)78:10<2101::AID-CNCR10>3.0.CO;2-2","article-title":"Spontaneous apoptosis in gallbladder carcinoma: relationships with clinicopathologic factors, expression of E-cadherin, -2 protooncogene, and p53 oncosuppressor gene","volume":"78","author":"Sasatomi","year":"1996","journal-title":"Cancer"},{"issue":"14","key":"10.1016\/j.critrevonc.2025.104830_bib231","doi-asserted-by":"crossref","first-page":"7008","DOI":"10.18632\/aging.204889","article-title":"KNTC1 and MCM2 are the molecular targets of gallbladder cancer","volume":"15","author":"Jia","year":"2023","journal-title":"Aging"},{"key":"10.1016\/j.critrevonc.2025.104830_bib232","article-title":"Molecular pathogenesis of gallbladder cancer: an update","volume":"816","author":"Mishra","year":"2019","journal-title":"Mutat. Res Mol. Mech. Mutagen"},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104830_bib233","doi-asserted-by":"crossref","first-page":"10153","DOI":"10.1007\/s11033-022-07874-4","article-title":"MAP kinase and mammalian target of rapamycin are main pathways of gallbladder carcinogenesis: results from bioinformatic analysis of next generation sequencing data from a hospital-based cohort (NCT05404347)","volume":"49","author":"Rajput","year":"2022","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib234","doi-asserted-by":"crossref","first-page":"22087","DOI":"10.1038\/s41598-020-77939-6","article-title":"Genomic profiling reveals high frequency of DNA repair genetic aberrations in gallbladder cancer","volume":"10","author":"Abdel-Wahab","year":"2020","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104830_bib235","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.gene.2013.01.019","article-title":"DCC (deleted in colorectal carcinoma) gene variants confer increased susceptibility to gallbladder cancer (Ref. No.: Gene-D-12-01446)","volume":"518","author":"Rai","year":"2013","journal-title":"Gene"},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104830_bib236","first-page":"2511","article-title":"Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile","volume":"55","author":"Wistuba","year":"1995","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib237","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cancergencyto.2008.02.016","article-title":"Rearrangement and allelic imbalance on chromosome 5 leads to homozygous deletions in the CDKN2A\/2B tumor suppressor gene region in rat endometrial cancer","volume":"184","author":"Adamovic","year":"2008","journal-title":"Cancer Genet Cytogenet"},{"issue":"18","key":"10.1016\/j.critrevonc.2025.104830_bib238","doi-asserted-by":"crossref","first-page":"467","DOI":"10.21037\/atm.2019.08.67","article-title":"Precision oncology for gallbladder cancer: insights from genetic alterations and clinical practice","volume":"7","author":"Lin","year":"2019","journal-title":"Ann. Transl. Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib239","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-03086-1","article-title":"Identification and verification of the molecular mechanisms and prognostic values of the cadherin gene family in gastric cancer","volume":"11","author":"Luo","year":"2021","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104830_bib240","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0304-3835(03)00385-9","article-title":"Expression of Fhit, Mlh1, and P53 protein in human gallbladder carcinoma","volume":"199","author":"Koda","year":"2003","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2025.104830_bib241","first-page":"136","article-title":"Deficient mismatch repair\/microsatellite unstable colorectal cancer: Diagnosis, prognosis and treatment","volume":"175","author":"Taieb","year":"2022","journal-title":"Eur. J. Cancer Oxf. Engl. 1990"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104830_bib242","article-title":"Experimental exchange of paralogous domains in the MLH family provides evidence of sub-functionalization after gene duplication","volume":"11","author":"Furman","year":"2021","journal-title":"G3 Bethesda Md"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104830_bib243","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s12029-017-0008-9","article-title":"Expression analysis of survivin and XIAP in gallbladder cancer: a case-control study in Indo-Gangetic plain","volume":"49","author":"Dixit","year":"2018","journal-title":"J. Gastrointest. Cancer"},{"key":"10.1016\/j.critrevonc.2025.104830_bib244","unstructured":"LncRNA-PAGBC acts as a microRNA sponge and promotes gallbladder tumorigenesis | EMBO reports [Internet]. [cited 2024 Nov 13]. Available from: \u3008https:\/\/www.embopress.org\/doi\/full\/10.15252\/embr.201744147\u3009."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104830_bib245","first-page":"549","article-title":"Bile cell\u2011free DNA as a novel and powerful liquid biopsy for detecting somatic variants in biliary tract cancer","volume":"42","author":"Shen","year":"2019","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104830_bib246","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s12253-017-0380-6","article-title":"Diagnostic value of circulating Free DNA integrity and global methylation status in gall bladder carcinoma","volume":"25","author":"Kumari","year":"2019","journal-title":"Pathol. Oncol. Res"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104830_bib247","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12253-016-0087-0","article-title":"Quantification of circulating free DNA as a diagnostic marker in gall bladder cancer","volume":"23","author":"Kumari","year":"2017","journal-title":"Pathol. Oncol. Res"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104830_bib248","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.3390\/cancers16071400","article-title":"Liquid biopsy for detection of pancreaticobiliary cancers by functional enrichment and immunofluorescent profiling of circulating tumor cells and their clusters","volume":"16","author":"Gaya","year":"2024","journal-title":"Cancers (Basel)"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825002185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825002185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T01:14:11Z","timestamp":1758590051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842825002185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":248,"alternative-id":["S1040842825002185"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104830","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global perspective on the genetic, epigenetic, and transcriptomic basis of gallbladder cancer","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104830","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104830"}}